ROCKET PHARMACEUTICALS INC's ticker is RCKT and the CUSIP is 77313F106. A total of 57 filers reported holding ROCKET PHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is 0.29 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $18,710,000 | -30.2% | 1,247,366 | -18.4% | 1.47% | -30.8% |
| Q1 2019 | $26,819,000 | +3.2% | 1,529,032 | -12.8% | 2.12% | -2.0% |
| Q4 2018 | $25,978,000 | -39.8% | 1,752,902 | 0.0% | 2.17% | -13.3% |
| Q3 2018 | $43,156,000 | +25.4% | 1,752,902 | 0.0% | 2.50% | +34.0% |
| Q2 2018 | $34,409,000 | +16.3% | 1,752,902 | +11.0% | 1.86% | +3.8% |
| Q1 2018 | $29,598,000 | – | 1,578,569 | – | 1.80% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| M28 Capital Management LP | 523,280 | $10,722,007 | 12.30% |
| RTW INVESTMENTS, LP | 17,687,772 | $362,422,448 | 7.65% |
| Logos Global Management LP | 1,975,000 | $40,467,750 | 5.40% |
| ACUTA CAPITAL PARTNERS, LLC | 362,000 | $7,417,380 | 4.97% |
| New Leaf Venture Partners, L.L.C. | 118,242 | $2,422,779 | 3.11% |
| MAVERICK CAPITAL LTD | 5,629,970 | $115,358,085 | 2.60% |
| Ghost Tree Capital, LLC | 295,000 | $6,044,550 | 1.99% |
| Frazier Life Sciences Management, L.P. | 1,403,013 | $28,747,736 | 1.91% |
| Ikarian Capital, LLC | 654,726 | $13,415,335 | 1.61% |
| Boxer Capital, LLC | 1,466,051 | $30,039,385 | 1.60% |